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There is growing evidence that medicinal herbs and
their ingredients enhance immune responses to vacci-
nation against infectious diseases (Liu & Xiao, 1992;
Rajput et al., 2007a). Medicinal herbs have a variety
of effects on immune responses and co-administration
of vaccine with herbal extracts shows an increase in
antibody response as well as enhancement in prolife-
rative response of T cells (Hu et al., 2003; Sun et al.,
2007). Some adjuvants such as Quillaja saponaria-A
extracts (Quil-A) or extracts from Cochinchina mo-
mordica seed (ECMS) have proven to be very effective
for enhancing immune responses with the commercial
foot-and-mouth disease (FMD) vaccine (Xiao et al.,
2007a,b,c). Quil-A is produced from the bark of Quilla-
ja saponaria Molina, a tree of the rose family which
is indigenous to South America; it is a triterpenoid sa-
ponin which has been used over the past three decades
as adjuvant in vaccines (Remington et al., 1918;
Kensil, 1996). ECMS is a crude extract made from seed
of the Chinese traditional medicinal plant Momordica
cochinchinensis and its immunomodulatory effects
have been reported in vaccines against influenza-H5N1
(Rajput et al., 2007b), infectious bursal disease (Rajput
et al., 2010) and newcastle disease (Xiao et al., 2009)
in chicken. The immunomodulatory effect of ECMS
was also reported against foot-and-mouth disea-
se vaccination in Guinea pigs and pigs (Xiao et al.,
2007c), and in mice (Sakwiwatkul et al., 2010). Tra-
ditionally, the seed has been used for a variety of ail-
ments including inflammatory swelling, diarrhea, and
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Abstract
This study was designed to evaluate the effects of oral administration of extracts from Cochinchina momordica seed
(ECMS) or Quillaja saponaria-A (Quil-A) on the immune responses in mice immunized with foot and mouth disease
virus (FMDV)-serotype O vaccine. Forty-two imprinting control region (ICR) mice were randomly divided into seven
groups of 6 animals in each group, and a dose of 400 µg of Quil-A or ECMS was orally administered for 1, 2 or 3 days.
After that, the animals were subcutaneously immunized twice with FMD vaccine at 3-week intervals and blood samples
were collected 2-weeks after boosting for measurement of FMDV-specific IgG and its subclasses. Spleens were collected
for lymphocytes proliferation assay. Results indicated that serum FMDV-specific IgG and the IgG subclass responses
were significantly enhanced in mice orally administered ECMS or Quil-A when compared with the control group (p < 0.05).
Lymphocytes proliferation response to FMD vaccine was significantly enhanced by ECMS compared with the control
(p < 0.05). This study illustrates that ECMS induced immunomodulatory effects and performed better than Quil-A.
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supportive skin infections in human and animals (Gao,
2005).
The present study was designed to investigate the
effects of oral administration of Quil-A or ECMS on the
immune responses in mice immunized with a commer-
cial serotype-O FMDV vaccine.
The ECMS was extracted following Xiao et al.
(2007a). Quil-A was supplied by Desert King Chile Ltd.,
Santiago, Chile. Commercially available FMD vaccine
(serotype-O) adjuvanted with oil was produced by Lan-
zhou Veterinary Research Institute (LVRI), China.
Forty-two female imprinting control region (ICR)
mice, purchased from Zhejiang Experimental Animal
Center (Hangzhou, China), were housed in polypropy-
lene cages with sawdust bedding in hygienically con-
trolled environment and provided standard food and
water ad libitum. Mice were randomly distributed into
seven groups, each group comprising six animals. The
mice of each group were treated as shown in Table 1.
Briefly, each mouse were orally administered 400 µg
(800 µg mL–1) Quil-A or ECMS using oral syringes
medicinal dropper to groups Quil-A1 or ECMS1 (on
Day 3 and boosted on Day 25), Quil-A2 or ECMS2 (on
Days 2 and 3 and boosted on Days 24 and 25) and Quil-
A3 or ECMS3 (on Days 1, 2 and 3 and boosted on Days
23, 24 and 25). Control group was orally administered
saline (0.9% NaCl) (on Days 1, 2 and 3 and boosted on
Days 23, 24 and 25). Total volume of liquid orally admi-
nistered to each mouse was 0.5 mL. On Day 4, all ani-
mals (including control) were subcutaneously injected
with 200 µL of FMDV (serotype-O) vaccine and boosted
with 3-weeks interval (on Day 26). The group receiving
saline and FMD vaccine served as control. Two weeks
after the booster dose (Day 40), blood samples were
collected from all groups for measurement of serum
FMDV-specific IgG and IgG subclasses. On the same
day, the spleens from group Quil-A3, ECMS3 and con-
trol were collected for lymphocytes proliferation assay.
Serum samples were analyzed for measurement of
FMDV-specific IgG antibodies and isotypes by an in-
direct double antibody sandwich enzyme-linked immu-
nosorbent assay (ELISA) as described by Song et al.
(2009). All the wells of polyvinyl 96-well microtitre
plates were coated with 50 µL rabbit anti-FMDV (type
O) antibody (LVRI, China) diluted in 0.05 M carbo-
nate/bicarbonate buffer (1:800), pH 9.6 and incubated
overnight at 4°C. After five washes with phosphate buffer
saline containing 0.05% Tween-20 (PBST), the wells
were blocked with 5% skimmed milk and incubated at
37°C for 2 h. PBST was also used as a diluent and washing
solution in all subsequent steps. Thereafter, 50 µL FMDV
(type O) antigen (LVRI) (1:3 dilution) was added and
incubated at 4°C for 2 h. After wash, 50 µL of serum
samples (1:50) was added to duplicate wells and incu-
bated at 37°C for 1 h. Following five washings, 50 µL
of goat anti-mice IgG (1:500) (Kirkegaard, Perry Lab,
MD, USA) was added to all wells and incubated at
37°C for 1 h. For subclass, 100 µL of biotin conjugated
goat anti-mouse IgG1, IgG2a, IgG2b or IgG3 (1:600
dilution, Santa Cruz Biotechnol Inc, CA, USA) was
added to the corresponding plate and then incubated
for 1 h at 37°C. After washing, 100 µL of horseradish
peroxidase conjugated anti-biotin (BD Biosciences,
Pharmingen, USA) diluted 1:4000 in PBST was added
to each well and incubated for 1 h at 37°C. Plates were
washed again with PBST. Fifty microliters of TMB
solution (100 µg mL–1 of 0.1 M citrate-phosphate, pH
5.0) was added to each well and incubated for 15 min
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Table 1. Treatment schedule of Quillaja saponaria-A (Quil-A), extracts from Cochinchina momordica seed (ECMS) and
foot and mouth disease (FMD) vaccine to mice (n = 6)
Immunization Sample collection
Groups
Oral administration Injection
Blood Lymphocytes
(400 µg Quil-A or ECMS) (200 µL FMD vaccine)
Days 1 and 23 Days 2 and 24 Days 3 and 25 Days 4 and 26 Day 40 Day 40
Control (Saline) – – – + + +
Quil-A1 – – + + + –
Quil-A2 – + + + + –
Quil-A3 + + + + + +
ECMS1 – – + + + –
ECMS2 – + + + + –
ECMS3 + + + + + +
+: activity. –: inactivity.
at 37°C. The reaction was stopped by adding 50 µL of
2 M H2SO4 to each well. The optical density of the plate
was read by an automatic ELISA plate reader at 450 nm.
Mice were sacrificed and spleens were collected un-
der aseptic conditions for lymphocyte proliferation assay
as described previously (Li et al., 2009). In brief, spleens
were minced and passed through a fine steel mesh to
obtain a homogeneous cell suspension. Cells were sus-
pended in RPMI-1640 (Gibco, Bio-cult, Glasgow, UK)
containing 300 mg glutamine L–1, 2 g sodium bicar-
bonate L–1, 10% calf serum and 50 µg gentamicin mL–1.
Cells were counted with a haemocytometer by trypan
blue exclusion technique and suspension was adjusted
to 3 × 106 viable cells mL–1. The assay was carried out
in a flat-bottom 96-well microplate, where the cells in
100 µL medium were cultured in a humid atmosphere
in 5% CO2 at 37°C for 68 h. Wells with FMDV (O type)
at 50 µg mL–1 were used as stimulators while wells
without mitogens served as control. After incubation,
50 µL of MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyl-tetrazolium bromide] (Amresco, Cleveland,
OH, USA) solution (2 mg mL–1) was added to each well,
and incubated for another 4 h. The plates were then
centrifuged (400 g, 5 min) and the untransformed MTT
was removed carefully using a pipette. To each well,
150 µL of a DMSO working solution (144 µL of DMSO
with 6 µL 1 N HCl) was added and incubated for 15
min at 37°C to dissolve crystallisable formazan. The
plates were read by an ELISA reader at 490 nm. The
stimulation index (SI) was calculated based on the follo-
wing formula: SI = OD value for mitogen-cultures/OD
value for non-stimulated cultures. Data analysis was
performed with SPSS software (vers. 11.5, SPSS Inc.,
Chicago, IL, USA) at 0.05 level of significance.
Responses of FMDV-specific IgG antibodies were
significantly higher (p < 0.05) in mice orally adminis-
tered Quil-A or ECMS as compared to the control group
(p < 0.05) (Fig. 1a). A significant increase in IgG1 anti-
body level in serum was observed in mice that received
ECMS for Day 1 or Day 3 as compared to the control
group. Similarly, a significant increases of IgG2a and
IgG3 levels were recorded in all groups of mice treated
with Quil-A or ECMS (p < 0.05) as compared to the
control (Fig. 1b). IgG2b antibody level was signifi-
cantly higher than control in mice administered ECMS
on Day 1. The proliferative response of Quil-A and
ECMS on lymphocytes is shown in Fig. 1c. Stimulating
index (SI) for the proliferation in response to FMDV
was significantly increased (p < 0.05) in mice of group
ECMS3 (which received ECMS three days before
vaccination), when compared to the control.
In the present work, the enhancement of immune
responses to vaccination against FMD was studied in
mice model by oral administration of Quil-A or ECMS.
Quil-A is a saponin fraction successfully used for vete-
rinary applications (Dalsgaard, 1987). Significant in-
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Figure 1. Immune response of mice to foot and mouth disease (FMD) vaccine (type O) with or without oral administration of Quil
A or ECMS adjuvants. FMDV (type O) specific IgG antibodies (a), FMDV (type O) specific IgG subclasses (b) and lymphocytes
proliferation (c). Different letters a,b,c indicate significant differences between groups (p < 0.05).
a)
c)
b)
crease of humoral immune response has been reported
in pigs immunized with FMD vaccine supplemented
with Quil A (Xiao et al., 2007b). ECMS has also been
reported to have an adjuvant effect in FMD vaccina-
tion, with a much lower hemolytic activity (Xiao et al.,
2007a). However, to our understanding, this is the first
report of the adjuvant activity of Quil-A or ECMS 
by oral administration. Oral administration of these
two adjuvants, significantly increased serum specific
IgG and its subclasses in mice inoculated with FMD
vaccine.
Humoral immune response has been considered to
be an important defense mechanism in FMD virus in-
fection (Meloen et al., 1979; Brown, 1995), and the
contribution of antibodies to the major immune defen-
se against the virus is clear (McCullough et al., 1988,
1992). Studies with animal models (McCullough et al.,
1986, 1988) have shown that specific antibodies play
an important role in the immune defense against FMD
virus. However, poor humoral immune responses to
FMD vaccination, in laboratory animals and pigs, have
been reported previously (Shi et al., 2007; Xiao et al.,
2007b). Fig. 1a shows that oral administration of Quil-
A or ECMS significantly increased serum FMDV-spe-
cific IgG antibody to a commercial FMD vaccine. This
finding corroborates with Sakwiwatkul et al. (2010).
Study of the IgG isotypes elicited in response to
viral infection or immunization is therefore important
when considering the mechanisms of in vivo protection
(Pérez Filgueira et al., 1995). The formation of IgG2a
is typical for the Th1 response, while IgG1 is typical
for Th2 response (Giese, 1998). Both IgG2a and IgG2b
isotypes are the most effective in complement activa-
tion as well as in antibody-mediated cellular responses
(Klaus et al., 1979; Kipps et al., 1985). Present study
showed that the oral administration significantly in-
creased the IgG subclasses (Quil-A, IgG2a, IgG3 and
ECMS; IgG1, IgG2a, IgG2b and IgG3) as depicted in
Fig. 1B. So, it is concluded that Quil-A induced Th1
type immune response while ECMS produced both Th1
and Th2 type responses. Th2 type cells have been re-
ported to be efficient in inducing an antibody response
to protein antigens (Rodriguez et al., 1996).
Present study revealed that IgG3 was the predomi-
nant isotype among total anti-FMDV IgG subclasses
(Fig. 1b). The IgG3 subclass presents the tendency to
form aggregates by non-covalent bonds between the
Fc region of other adjacent IgG3 molecules and fixes com-
plement poorly (Grey et al., 1971; Greenspan & Cooper,
1992). It has also been reported that all monoclonal
antibodies (MAbs) that caused FMDV aggregation
were of the IgG3 subclass (Baxt et al., 1984). Viral neu-
tralization produced by the mechanism of aggregation
might be isotype-related (Baxt et al., 1984; Greenspan
& Cooper, 1992).
Lymphocytes of the three groups (Quil-A, ECMS3
and control) were stimulated by FMDV (type O) anti-
gen (Fig. 1c). FMDV (type O)-induced lymphocyte
proliferation response was significantly enhanced in
ECMS 3 group, but there was no change in Quil-A group.
This observation suggests that ECMS has the potential
to activate T as well as B cells. In present study, it is
concluded that ECMS induced more immunomodu-
latory effects compared to Quil-A and more safe as re-
ported previously.
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